JONES WILLIAM A JR

CIK 00013730976 companiesNAARDEN, P7

SEC Profile

Transactions

Companies

Filings

CIK

0001373097

Recent Transactions

50 trades

Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2025-06-05+55,000→ 55,000 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2025-01-09+88,000→ 88,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-07+43,000→ 43,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-02+200,000→ 200,000 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2024-06-05+10,370→ 10,370 total
Award
Akili, Inc.
Stock Option (Right to Buy)
2023-05-02+22,000→ 22,000 total
Award
Akili, Inc.
Stock Option (Right to Buy)
2022-11-02+44,000→ 44,000 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−28,258→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−1,742→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−5,913→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−44,087→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-10-03−10,000→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-10-03−11,250→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−775→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−29,225→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−2,398→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Stock Options (Right to Buy)
2022-10-03−37,602→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2022-10-03$148.50/sh−14,226→ 0 total
Disposition to Issuer
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-10-03−3,000→ 0 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2022-01-07+3,750→ 15,630 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-01-07−3,750→ 11,250 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (right to buy)
2022-01-07+30,000→ 30,000 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2022-01-07$128.87/sh−1,631→ 13,999 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-01-07+15,000→ 15,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2022-01-06−5,000→ 10,000 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2022-01-06$123.86/sh−2,230→ 11,880 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2022-01-06+5,000→ 14,110 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2021-11-25$115.55/sh−1,305→ 8,822 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2021-11-25+3,000→ 10,127 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2021-11-25−3,000→ 3,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2021-01-06+5,000→ 9,251 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2021-01-06$83.38/sh−2,124→ 7,127 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2021-01-06+20,000→ 20,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (right to buy)
2021-01-06+40,000→ 40,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2021-01-06−5,000→ 15,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2020-11-25−3,000→ 6,000 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2020-11-25$90.14/sh−1,245→ 3,510 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2020-11-25+3,000→ 4,755 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (Right to Buy)
2020-11-02−30,000→ 50,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2020-11-02$50.72/sh+30,000→ 31,755 total
Sale
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2020-11-02$77.70/sh−1,300→ 1,755 total
Sale
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2020-11-02$76.02/sh−24,690→ 7,065 total
Sale
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2020-11-02$77.01/sh−4,010→ 3,055 total
Tax Payment
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2019-12-18$52.13/sh−1,245→ 1,755 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Common Shares
2019-12-18+3,000→ 3,000 total
Exercise/Conversion
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2019-12-18−3,000→ 9,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (Right to Buy)
2019-11-25+30,000→ 30,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Restricted Share Unit Award
2019-11-25+12,000→ 12,000 total
Award
Biohaven Pharmaceutical Holding Co Ltd.
Employee Stock Option (Right to Buy)
2019-04-01+80,000→ 80,000 total

Companies

Recent Filings

Address

C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35

NAARDEN, P7, 1411 DC

View on SEC.gov